Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy

Since its first recognition in Wuhan, China, in December 2019, the COVID-19 pandemic caused by the novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2) has rapidly spread across the globe. In the absence of effective treatments or vaccines, measures have been deployed to slow the spreading of the viral infection by implementing social distancing and lockdowns of large sections of the society. In Italy, a nationwide lockdown was imposed from March 9th through May 3rd, 2020. For people with diabetes the lockdown can be expected to exert a negative impact on the management of the disease due to the anxiety and depression that can be generated by the concern about the risk of infection for them and their relatives as well as because of the uncertainties about medical and pharmacologic supply and the possibility to access regularly consultation with health care providers.
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research